Collaboration/cooperation with external institutions Overseas organizations and global consortiums
Through collaboration/cooperation with external institutions including overseas institutions and global consortiums, AMED accelerates R&D in the medical field and attempts to contribute to “three essential phases of “life” (biological life, day-to-day life and life from birth to death)” of patients and their families.
Consortium etc.
- The Matchmaker Exchange (MME)
- The International Rare Diseases Research Consortium (IRDiRC)
- GloPID-R (Global Research Collaboration for Infectious Disease Preparedness）
- Joint Programming Initiative on Antimicrobial Resistance (JPIAMR)
- The International Human Epigenome Consortium (IHEC)
- To Promote Data Sharing in the World
- Global Alliance for Chronic Diseases
- Joining the Clinical Data Interchange Standards Consortium (CDISC)
- GA4GH (Global Alliance for Genomics and Health)
Between Two Agencies ー Memorandum of Cooperation (MOC)
- Australia - The National Health and Medical Research Council of Australia (NHMRC); October 17th, 2018
- Spain - The Secretariat of State for Research, Development and Innovation (SEIDI); April 5th, 2017
- Lithuania – Ministry of Health; March 9th, 2017
- United Kingdom – Medical Research Council (MRC); February 1st, 2017
- Singapore – Agency for Science, Technology and Research (A*STAR); March 16th, 2016
- Cooperation with Singapore
- United States – National Institute of Health (NIH); January 11th, 2016
- 50th Anniversary Celebration of the U.S.-Japan Cooperative Medical Sciences Program and Activities under the Program
- Memorandum of Cooperation signed with U.S. National Institutes of Health; updates on specific collaborative activities
Participation in international research cooperation
09/06/17
Last updated 09/28/20